Recode Studios IPO Launches Today: Essential GMP Insights to Guide Your Subscription Decision!

The IPO of Recode Studios, a burgeoning player in the beauty and personal care sector, is set to open for subscription on May 5, 2026. This SME issue, valued at ₹44.6 crore, is priced between ₹150 and ₹158 per share, with investors keen on the company’s strategy of establishing an omnichannel cosmetics brand in a market largely dominated by larger firms. The listing on the BSE SME platform is anticipated for May 12. An anchor investment of ₹12.7 crore has already been secured, showcasing institutional confidence before the public offering.

Currently, the grey market sentiment surrounding Recode Studios presents a mixed picture. Recent reports indicate a zero premium on the stock, suggesting that there are expectations for a flat listing around the upper price band of ₹158. This muted grey market response contrasts with initial hopes for a more substantial listing gain, highlighting potential investor caution amidst the competitive landscape of the beauty industry.

For Indian investors, Recode Studios’ IPO presents both opportunities and challenges. While the company has shown significant revenue growth, reporting a total income of ₹57.5 crore over nine months with a net profit of ₹9.1 crore, the indeterminate grey market sentiment may temper enthusiasm. Investors should weigh the company’s growth prospects and operational strategies against the current market dynamics, carefully considering the long-term potential of entering a sector known for its volatility and fierce competition.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)